(Q51751824)

11 April 2018

title

Self-administration of intravenous nicotine in male and female cigarette smokers. (English)

1 reference

11 April 2018

0 references

Mehmet Sofuoglu

1

1 reference

11 April 2018

Sonah Yoo

series ordinal

2

1 reference

11 April 2018

Kevin P Hill

series ordinal

3

1 reference

11 April 2018

Marc Mooney

series ordinal

4

1 reference

11 April 2018

language of work or name

English

0 references

publication date

30 May 2007

1 reference

11 April 2018

published in

Neuropsychopharmacology

1 reference

11 April 2018

volume

33

1 reference

11 April 2018

issue

4

1 reference

11 April 2018

page(s)

715-720

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301460

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Rate of increase of plasma drug level influences subjective response in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Ethanol self-administration in males with and without an alcoholic first-degree relative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Doses of nicotine and lung carcinogens delivered to cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Control of behavior by intravenous nicotine injections in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Signs and symptoms of tobacco withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Do former smokers respond to nicotine differently from never smokers? A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Predicting relapse back to smoking: contrasting affective and physical models of dependence

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

21 January 2018

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

inferred from DOI database lookup

7 January 2021

based on heuristic

Nicotine as a typical drug of abuse in experimental animals and humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Threshold doses for nicotine discrimination in smokers and non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Nicotine preference in smokers as a function of smoking abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Nicotine self-administration in animals and humans: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Comparison of three nicotine treatments: initial reactions and preferences with guided use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Development and validation of brief measures of positive and negative affect: The PANAS scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Individual differences in preferences for and responses to four nicotine replacement products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

Cigarette smokers self-administer intravenous nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparative testing of 5 nicotine systems: initial use and preferences.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301460

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1301460

1 reference

11 April 2018

PubMed ID

17534380

1 reference

11 April 2018